Somapacitan

Somapacitan is a drug used for the treatment of growth hormone deficiency in adults. It is a growth hormone analog that is administered once weekly, and it works by stimulating growth and cell reproduction in the body.

Mechanism of Action

Somapacitan works by binding to the growth hormone receptor on the surface of cells. This binding triggers a series of reactions within the cell that lead to the growth and reproduction of cells.

Uses

Somapacitan is used to treat adults with growth hormone deficiency. This condition can cause a variety of symptoms, including decreased muscle mass, increased body fat, and decreased bone density. By providing a steady supply of growth hormone, somapacitan can help to alleviate these symptoms.

Side Effects

Like all drugs, somapacitan can cause side effects. The most common side effects include injection site reactions, muscle pain, joint pain, and headache. In rare cases, somapacitan can cause more serious side effects, such as high blood sugar levels or an allergic reaction.

History

Somapacitan was developed by the Danish pharmaceutical company Novo Nordisk. It was approved for use in the European Union in 2020, and in the United States in 2021.

See Also

• Growth hormone
• Growth hormone deficiency
• Novo Nordisk

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia